Skip to main content
SpringerLink
Log in

Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

This study aims to investigate the preventive effect of oral nicorandil on contrast-induced nephropathy (CIN) in patients with renal insufficiency undergoing elective cardiac catheterization. A total of 240 patients with an estimated glomerular filtration rate (eGFR) of 60 mL/min or less, who were undergoing elective cardiac catheterization, were randomly assigned to nicorandil group (n = 120, 10 mg nicorandil, three times daily from 2 days before to 3 days after procedure) or control group (n = 120, matching placebo as the same method). The primary endpoint was the incidence of CIN defined as 25 % increase in serum creatinine (SCr) from baseline or 44 μmol/L (0.5 mg/dL) increase in absolute value within 72 h after exposure to contrast medium. The secondary endpoints were: (1) the changes of SCr, Cystatin-C (Cys-C) and eGFR within 72 h; (2) major adverse events (MACE) occurring within 30 days. Baseline characteristics of the patients in the two groups were similar. The incidence of CIN was significantly lower in nicorandil group compared with control group (6.67 vs. 17.5 %, P = 0.017). Compared with the control group, nicorandil group tended to have a lower SCr and Cys-C levels as well as a higher eGFR at 48 h after the procedure (all P < 0.05). There was no difference about the incidence of MACE within 30 days between nicorandil group and control group (4.16 vs. 5.83 %, P = 0.767). Multivariate logistic analysis showed that nicorandil was an independent protective factor against CIN (OR = 0.260, 95 % CI = 0.1–0.676, P = 0.006). Therefore, we concluded that oral nicorandil was associated with a decline in the incidence of CIN in patients with renal insufficiency undergoing elective cardiac catheterization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W (2012) A European renal best practice (ERBP) position statement on the kidney disease improving global outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transpl 27:4263–4272

    Article  Google Scholar 

  2. McCullough PA (2008) Contrast-induced acute kidney injury. J Am Coll Cardiol 51:1419–1428

    Article  PubMed  Google Scholar 

  3. Brown JR, Malenka DJ, DeVries JT, Robb JF, Jayne JE, Friedman BJ, Hettleman BD, Niles NW, Kaplan AV, Schoolwerth AC, Thompson CA (2008) Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry. Catheter Cardiovasc Interv 72:347–354

    Article  PubMed  Google Scholar 

  4. Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, Pichard AD, Satler LF, Wu H, Leon MB (2001) Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 52:409–416

    Article  CAS  PubMed  Google Scholar 

  5. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365–3370

    Article  PubMed  Google Scholar 

  6. Ogita M, Sakakura K, Nakamura T, Funayama H, Wada H, Naito R, Sugawara Y, Kubo N, Ako J, Momomura S (2012) Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention. Heart Vessel 27:460–467

    Article  Google Scholar 

  7. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399

    PubMed  Google Scholar 

  8. Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z (2015) Risk prediction models for contrast induced nephropathy: systematic review. BMJ 351:h5401

    Google Scholar 

  9. Azzalini L, Spagnoli V, Ly HQ (2015) Contrast-induced nephropathy: from pathophysiology to preventive strategies. Can J Cardiol. doi:10.1016/j.cjca.2015.05.013

    Google Scholar 

  10. Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Almen T, Aspelin P, Bellin MF, Clement O, Heinz-Peer G (2011) Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 21:2527–2541

    Article  PubMed  Google Scholar 

  11. Andreucci M, Faga T, Pisani A, Sabbatini M, Russo D, Michael A (2014) Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors. Sci World J 2014:823169

    Article  Google Scholar 

  12. Li WH, Li DY, Qian WH, Liu JL, Xu TD, Zhu H, He HY (2014) Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention. Int Urol Nephrol 46:781–786

    Article  CAS  PubMed  Google Scholar 

  13. Xing K, Fu X, Wang Y, Li W, Gu X, Hao G, Miao Q, Li S, Jiang Y, Fan W, Geng W (2015) Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI. Heart Vessel. doi:10.1007/s00380-015-0642-8

    Google Scholar 

  14. Gare M, Haviv YS, Ben-Yehuda A, Rubinger D, Bdolah-Abram T, Fuchs S, Gat O, Popovtzer MM, Gotsman MS, Mosseri M (1999) The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 34:1682–1688

    Article  CAS  PubMed  Google Scholar 

  15. Chong E, Poh KK, Lu Q, Zhang JJ, Tan N, Hou XM, Ong HY, Azan A, Chen SL, Chen JY, Ali RM, Fang WY, Lau TW, Tan HC (2015) Comparison of combination therapy of high-dose oral N-acetylcysteine and intravenous sodium bicarbonate hydration with individual therapies in the reduction of contrast-induced nephropathy during cardiac catheterisation and percutaneous coronary intervention (CONTRAST): a multi-centre, randomised, controlled trial. Int J Cardiol 201:237–242

    Article  PubMed  Google Scholar 

  16. Caixeta A, Dogan O, Weisz G (2012) Contrast-induced nephropathy: protective role of fenoldopam. Clin Exp Pharmacol Physiol 39:497–505

    Article  CAS  PubMed  Google Scholar 

  17. Giacoppo D, Capodanno D, Capranzano P, Aruta P, Tamburino C (2014) Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization. Am J Cardiol 114:541–548

    Article  CAS  PubMed  Google Scholar 

  18. Jurado-Roman A, Hernandez-Hernandez F, Garcia-Tejada J, Granda-Nistal C, Molina J, Velazquez M, Albarran A, Tascon J (2015) Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention. Am J Cardiol 115:1174–117819

    Article  PubMed  Google Scholar 

  19. IONA Study Group (2002) Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359:1269–1275

    Article  Google Scholar 

  20. Horinaka S, Yabe A, Yagi H, Ishimitsu T, Yamazaki T, Suzuki S, Kohro T, Nagai R (2010) Effects of nicorandil on cardiovascular events in patients with coronary artery disease in the Japanese Coronary Artery Disease (JCAD) study. Circ J 74:503–509

    Article  PubMed  Google Scholar 

  21. Ishii H, Ichimiya S, Kanashiro M, Amano T, Imai K, Murohara T, Matsubara T (2005) Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation 112:1284–1288

    Article  CAS  PubMed  Google Scholar 

  22. Kawai Y, Hisamatsu K, Matsubara H, Dan K, Akagi S, Miyaji K, Munemasa M, Fujimoto Y, Kusano KF, Ohe T (2009) Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon. Eur Heart J 30:765–772

    Article  CAS  PubMed  Google Scholar 

  23. Wu M, Huang Z, Xie H, Zhou Z (2013) Nicorandil in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. PLoS One 8:e78231

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nawa T, Nishigaki K, Kinomura Y, Tanaka T, Yamada Y, Kawasaki M, Minatoguchi S (2015) Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function. Int J Cardiol 195:228–234

    Article  PubMed  Google Scholar 

  25. Ko YG, Lee BK, Kang WC, Moon JY, Cho YH, Choi SH, Hong MK, Jang Y, Kim JY, Min PK, Kwon HM (2013) Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study). Yonsei Med J 54:957–964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tashiro Y, Yogo K, Serizawa K, Endo K (2015) Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats. Clin Exp Nephrol 19:343–349

    Article  CAS  PubMed  Google Scholar 

  27. Shimizu S, Saito M, Kinoshita Y, Ohmasa F, Dimitriadis F, Shomori K, Hayashi A, Satoh K (2011) Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney. Br J Pharmacol 163:272–282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254

    Article  CAS  PubMed  Google Scholar 

  29. Geng W, Fu XH, Gu XS, Wang YB, Wang XC, Li W, Jiang YF, Hao GZ, Fan WZ, Xue L (2012) Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty. Chin Med J (Engl) 125:3368–3372

    CAS  Google Scholar 

  30. Seeliger E, Sendeski M, Rihal CS, Persson PB (2012) Contrast-induced kidney injury: mechanisms, risk factors, and prevention. Eur Heart J 33:2007–2015

    Article  PubMed  Google Scholar 

  31. Rosenberger C, Rosen S, Heyman SN (2006) Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 33:980–988

    Article  CAS  PubMed  Google Scholar 

  32. Kwasa EA, Vinayak S, Armstrong R (2014) The role of inflammation in contrast-induced nephropathy. Br J Radiol 87:20130738

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Borekci A, Gur M, Turkoglu C, Cayli M, Selek S, Kaypakli O, Ucar H, Coskun M, Seker T, Koc M, Gokdeniz T, Gozukara MY (2015) Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology 66:339–345

    Article  CAS  PubMed  Google Scholar 

  34. Pisani A, Riccio E, Andreucci M, Faga T, Ashour M, Di NA, Mancini A, Sabbatini M (2013) Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy. Biomed Res Int 2013:868321

    Article  PubMed  PubMed Central  Google Scholar 

  35. Caiazza A, Russo L, Sabbatini M, Russo D (2014) Hemodynamic and tubular changes induced by contrast media. Biomed Res Int 2014:578974

    Article  PubMed  PubMed Central  Google Scholar 

  36. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S (1991) Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 88:390–395

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Yamada K, Isobe S, Ishii H, Yokouchi K, Iwata H, Sawada K, Murohara T (2015) Impacts of nicorandil on infarct myocardium in comparison with nitrate: assessed by cardiac magnetic resonance imaging. Heart Vessels. doi:10.1007/s00380-015-0752-3

    Google Scholar 

  38. Ota S, Nishikawa H, Takeuchi M, Nakajima K, Nakamura T, Okamoto S, Setsuda M, Makino K, Yamakado T, Nakano T (2006) Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: sigmart multicenter angioplasty revascularization trial (SMART). Circ J 70:1099–1104

    Article  CAS  PubMed  Google Scholar 

  39. Kato D, Takashima H, Waseda K, Kurita A, Kuroda Y, Kosaka T, Kuhara Y, Ando H, Maeda K, Kumagai S, Sakurai S, Suzuki A, Toda Y, Watanabe A, Sato S, Fujimoto M, Mizuno T, Amano T (2015) Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements. Heart Vessel 30:477–483

    Article  Google Scholar 

  40. Miki T, Seino S (2005) Roles of KATP channels as metabolic sensors in acute metabolic changes. J Mol Cell Cardiol 38:917–925

    Article  CAS  PubMed  Google Scholar 

  41. Sun Z, Zhang X, Ito K, Li Y, Montgomery RA, Tachibana S, Williams GM (2008) Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide. Am J Physiol Renal Physiol 294:F491–F498

    Article  CAS  PubMed  Google Scholar 

  42. Kawata T, Mimuro T, Onuki T, Tsuchiya K, Nihei H, Koike T (1998) The K (ATP) channel opener nicorandil: effect on renal hemodynamics in spontaneously hypertensive and Wistar Kyoto rats. Kidney Int Suppl 67:S231–S233

    Article  CAS  PubMed  Google Scholar 

  43. Tamura Y, Tanabe K, Kitagawa W, Uchida S, Schreiner GF, Johnson RJ, Nakagawa T (2012) Nicorandil, a K(atp) channel opener, alleviates chronic renal injury by targeting podocytes and macrophages. Am J Physiol Renal Physiol 303:F339–F349

    Article  CAS  PubMed  Google Scholar 

  44. Serizawa K, Yogo K, Tashiro Y, Koike N, Aizawa K, Hirata M, Ishizuka N (2013) Nicorandil ameliorated hypertensive renal injury without lowering blood pressure in spontaneously hypertensive rats. Pharmacology 91:92–103

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Xingtai People’s Hospital, Xingtai, 054000, China

    Yanming Fan, Qingmin Wei, Junna Cai, Yongtang Shi, Youliang Zhang, Limei Yao, Xiaogang Wang, Shupo Lin, Yilin Li, Jing Lv, Bin Zhou & Ruijuan Du

Authors
  1. Yanming Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qingmin Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Junna Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yongtang Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Youliang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Limei Yao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaogang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Shupo Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yilin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jing Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Bin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ruijuan Du
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qingmin Wei.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fan, Y., Wei, Q., Cai, J. et al. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization. Heart Vessels 31, 1776–1782 (2016). https://doi.org/10.1007/s00380-016-0809-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-016-0809-y

Keywords

Search

Navigation